EGFR-mutant NSCLC has a unique TME27 which presents with both significantly reduced levels of CD8+ TIL28, 29, 30 and diminished CD8+ TIL function,31 leading to impaired cytotoxicity and resulting poor response to ICIs. Here, CD8A is linked to non-small cell lung carcinoma.